S&P 500   4,402.20
DOW   34,440.88
QQQ   364.54
Flee to Healthcare Stocks if Recession Rears its Head?
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
3 Tasty Dividend Stocks With Value and Above-Average Yields
3 ETFs for the Conservative Investor to Buy and Hold
Forget NVDA. Buy this A.I. stock instead (Ad)
Stock market today: World shares track Wall Street's slump after Fed says rates may stay high in '24
5 NYSE-Listed Emerging Market Stocks For Income Investors
DOD Consultant's big 2024 prediction looks to be coming true (Ad)
Disney Denies Rumors of TV Sale, After Stock Jumps on News
Are These Consumer Staples Too Cheap for Investors To Ignore?
S&P 500   4,402.20
DOW   34,440.88
QQQ   364.54
Flee to Healthcare Stocks if Recession Rears its Head?
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
3 Tasty Dividend Stocks With Value and Above-Average Yields
3 ETFs for the Conservative Investor to Buy and Hold
Forget NVDA. Buy this A.I. stock instead (Ad)
Stock market today: World shares track Wall Street's slump after Fed says rates may stay high in '24
5 NYSE-Listed Emerging Market Stocks For Income Investors
DOD Consultant's big 2024 prediction looks to be coming true (Ad)
Disney Denies Rumors of TV Sale, After Stock Jumps on News
Are These Consumer Staples Too Cheap for Investors To Ignore?
S&P 500   4,402.20
DOW   34,440.88
QQQ   364.54
Flee to Healthcare Stocks if Recession Rears its Head?
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
3 Tasty Dividend Stocks With Value and Above-Average Yields
3 ETFs for the Conservative Investor to Buy and Hold
Forget NVDA. Buy this A.I. stock instead (Ad)
Stock market today: World shares track Wall Street's slump after Fed says rates may stay high in '24
5 NYSE-Listed Emerging Market Stocks For Income Investors
DOD Consultant's big 2024 prediction looks to be coming true (Ad)
Disney Denies Rumors of TV Sale, After Stock Jumps on News
Are These Consumer Staples Too Cheap for Investors To Ignore?
S&P 500   4,402.20
DOW   34,440.88
QQQ   364.54
Flee to Healthcare Stocks if Recession Rears its Head?
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
3 Tasty Dividend Stocks With Value and Above-Average Yields
3 ETFs for the Conservative Investor to Buy and Hold
Forget NVDA. Buy this A.I. stock instead (Ad)
Stock market today: World shares track Wall Street's slump after Fed says rates may stay high in '24
5 NYSE-Listed Emerging Market Stocks For Income Investors
DOD Consultant's big 2024 prediction looks to be coming true (Ad)
Disney Denies Rumors of TV Sale, After Stock Jumps on News
Are These Consumer Staples Too Cheap for Investors To Ignore?
Positive News SentimentPositive News
NASDAQ:AVTE

Aerovate Therapeutics (AVTE) Insider Trading & Ownership

$13.05
-0.42 (-3.12%)
(As of 09/20/2023 ET)
Compare
Today's Range
$12.65
▼
$13.68
50-Day Range
$13.05
▼
$18.88
52-Week Range
$12.65
▼
$30.79
Volume
94,588 shs
Average Volume
87,336 shs
Market Capitalization
$360.83 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$37.00
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media

Aerovate Therapeutics (NASDAQ:AVTE) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
19.30%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
8
Amount Of
Insider Selling
(Last 12 Months)
$5.46 M
Get AVTE Insider Trade Alerts

Want to know when executives and insiders are buying or selling Aerovate Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

AVTE Insider Buying and Selling by Quarter


Aerovate Therapeutics Insider Trades History

Export to Excel
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/6/2023Benjamin T DakeInsiderSell3,931$15.06$59,200.861,291  
8/7/2023Benjamin T DakeInsiderSell10,283$15.52$159,592.161,291  
7/28/2023Timothy P. NoyesCEOSell5,478$18.00$98,604.00  
7/17/2023Timothy P. NoyesCEOSell4,522$18.11$81,893.42  
7/6/2023Benjamin T DakeInsiderSell10,283$16.66$171,314.781,291  
7/3/2023Timothy P. NoyesCEOSell10,000$18.00$180,000.00  
6/5/2023Ralph NivenInsiderSell2,250$16.26$36,585.001,609  
5/19/2023Hunter GilliesInsiderSell65$19.50$1,267.503,251  
5/17/2023Hunter GilliesInsiderSell1,090$19.59$21,353.103,251  
5/8/2023Benjamin T DakeInsiderSell10,284$21.80$224,191.201,291  
5/5/2023Ralph NivenInsiderSell2,250$20.87$46,957.501,609  
5/3/2023Marinus VerwijsSVPSell759$20.79$15,779.61  
5/1/2023Timothy P NoyesCEOSell15,000$20.61$309,150.00693  
4/21/2023Hunter GilliesInsiderSell4,000$19.50$78,000.001,960  
4/6/2023Benjamin T. DakeinsiderSell10,283$18.17$186,842.111,609  
4/3/2023Timothy P. NoyesCEOSell15,000$19.39$290,850.00  
3/6/2023Benjamin T. DakeinsiderSell10,282$23.73$243,991.861,609  
3/1/2023Timothy P. NoyesCEOSell15,000$23.81$357,150.00  
2/6/2023Benjamin T. DakeinsiderSell10,284$24.59$252,883.561,609  
2/1/2023Timothy P. NoyesCEOSell15,000$22.68$340,200.00  
1/6/2023Benjamin T. DakeinsiderSell10,284$25.98$267,178.321,609  
1/3/2023Timothy P. NoyesCEOSell15,000$27.07$406,050.00  
12/12/2022George A EldridgeInsiderSell10,000$30.04$300,400.001,960  
12/8/2022George A EldridgeInsiderSell12,011$23.87$286,702.571,960  
12/5/2022Ralph NivenInsiderSell2,250$17.38$39,105.001,609  
12/1/2022Timothy P. NoyesCEOSell15,000$18.00$270,000.00  
11/30/2022George A EldridgeInsiderSell85$19.06$1,620.101,960  
11/23/2022George A EldridgeInsiderSell1,261$19.07$24,047.271,960  
11/21/2022George A EldridgeInsiderSell2$19.00$38.001,960  
11/18/2022George A EldridgeInsiderSell861$19.52$16,806.721,960  
11/11/2022Benjamin T. DakeinsiderSell6,198$20.69$128,236.62  
11/8/2022Benjamin T. DakeinsiderSell8,373$18.09$151,467.571,609  
11/2/2022Marinus VerwijsSVPSell1,130$18.89$21,345.70  
11/1/2022Timothy P. NoyesCEOSell1,038$19.50$20,241.00  
10/17/2022Benjamin T. DakeinsiderSell4,185$20.16$84,369.60  
10/14/2022Benjamin T. DakeinsiderSell110$20.05$2,205.50  
10/10/2022Benjamin T. DakeinsiderSell4,954$16.89$83,673.06  
10/7/2022Benjamin T. DakeinsiderSell10,520$16.01$168,425.20  
10/5/2022Ralph NivenInsiderSell2,250$15.75$35,437.501,609  
(Data available from 1/1/2013 forward)












AVTE Insider Trading Activity - Frequently Asked Questions

Who is on Aerovate Therapeutics's Insider Roster?

The list of insiders at Aerovate Therapeutics includes Benjamin T Dake, George A Eldridge, Hunter Gillies, Marinus Verwijs, Ralph Niven, Timothy P Noyes. Learn more on insiders at AVTE.

What percentage of Aerovate Therapeutics stock is owned by insiders?

19.30% of Aerovate Therapeutics stock is owned by insiders. Learn more on AVTE's insider holdings.

Which Aerovate Therapeutics insiders have been selling company stock?

The following insiders have sold AVTE shares in the last 24 months: Benjamin T Dake ($614,299.00), George A Eldridge ($629,614.66), Hunter Gillies ($100,620.60), Marinus Verwijs ($37,125.31), Ralph Niven ($205,740.00), and Timothy P Noyes ($309,150.00).

How much insider selling is happening at Aerovate Therapeutics?

Insiders have sold a total of 312,902 Aerovate Therapeutics shares in the last 24 months for a total of $6,553,933.34 sold.


More Insider Trading Tools from MarketBeat

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:
This page (NASDAQ:AVTE) was last updated on 9/21/2023 by MarketBeat.com Staff

My Account -